FCA Health Innovations II QP
Brentwood, US · Founded 2020 · Delaware limited partnership
Healthtech
Founders & leadership
NS
Nancy S AllenExecutive Officer, Promoter
AJ
Andrew J BouldinExecutive Officer, Promoter
JR
John R Burch, Jr.Executive Officer, Promoter
AF
A FCA Health Innovations II SLP, LLCSpecial Limited Partner
AF
A FCA Health Innovations II GP, LLCGeneral Partner
AF
A FCA Health Innovations II Management, LLCInvestment Manager
JA
James A PattonExecutive Officer, Promoter
C(
Charles (Todd) W JohnsonDirector, Promoter
MA
Matthew A KingDirector, Promoter
WH
Whitney H KalbExecutive Officer, Promoter
TK
Thomas K Hearn IIIDirector, Promoter
Reported raises · per SEC filings
Form D private placements▶$55.1MraisedFeb 2022 · 129 investors · Other Health CareRule 506(b)
Officers, directors & promoters on the filing
- Nancy S AllenExecutive Officer, Promoter
- Andrew J BouldinExecutive Officer, Promoter
- John R Burch, Jr.Executive Officer, Promoter
- A FCA Health Innovations II SLP, LLCExecutive Officer
- A FCA Health Innovations II GP, LLCExecutive Officer, Promoter
- A FCA Health Innovations II Management, LLCExecutive Officer
- James A PattonExecutive Officer, Promoter
- Charles (Todd) W JohnsonDirector, Promoter
- Matthew A KingDirector, Promoter
- Whitney H KalbExecutive Officer, Promoter
- Thomas K Hearn IIIDirector, Promoter
- Offering amount
- $66M
- Amount sold
- $55.1M
- Minimum investment
- $25K
- First sale
- Nov 2020
- Incorporated
- Limited Partnership, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.